Antimetabolite pemetrexed primes a favorable tumor microenvironment for immune checkpoint blockade therapy | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

XML

Basic tumor immunology

Original research

Antimetabolite pemetrexed primes a favorable tumor microenvironment for immune checkpoint blockade therapy

Online download statistics by month:

Online download statistics by month: November 2020 to March 2024

	Abstract	Full	Pdf
Nov 2020	178	178	89
Dec 2020	818	818	301
Jan 2021	307	307	136
Feb 2021	182	182	83
Mar 2021	201	201	80
Apr 2021	150	151	55
May 2021	171	171	65
Jun 2021	123	123	49
Jul 2021	122	122	61
Aug 2021	145	145	80
Sep 2021	188	188	95
Oct 2021	169	169	83
Nov 2021	148	148	78
Dec 2021	144	144	63
Jan 2022	136	145	64
Feb 2022	109	113	40
Mar 2022	136	141	61
Apr 2022	147	158	62
May 2022	166	169	75
Jun 2022	173	175	61
Jul 2022	140	144	60
Aug 2022	106	114	55
Sep 2022	108	115	159
Oct 2022	143	147	71
Nov 2022	107	107	74
Dec 2022	91	92	32
Jan 2023	88	90	44
Feb 2023	95	97	30
Mar 2023	113	114	67
Apr 2023	90	90	30
May 2023	80	82	34
Jun 2023	83	87	48
Jul 2023	93	94	28
Aug 2023	77	78	29
Sep 2023	80	81	30
Oct 2023	109	109	46
Nov 2023	94	95	43
Dec 2023	78	79	45
Jan 2024	32	33	29
Feb 2024	61	61	26
Mar 2024	106	106	95
Total	5887	5963	2756